HB
About
Kanglu Bio is positioned to provide clinical diagnosis and guidance for clinical drug molecular diagnostic products and clinical molecular diagnostics overall service providers for clinical hospitals and third-party clinical independent testing institutions. The products and services are mainly used in cardiovascular and cerebrovascular diseases. Major diseases such as tumors and cancer.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 73 investors are based in Wuhan, Hubei, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Wuhan, China
Contact Information
Find more investors like HealthCare
Search Investors